Jaguar Health (JAGX) Other Non Operating Income (2015 - 2026)
Jaguar Health (JAGX) reported Other Non Operating Income of -$628000.0 for Q1 2026, down 660.71% year-over-year from $112000.0 in Q1 2025, and down 133.67% quarter-over-quarter from $1.9 million in Q4 2025.
Jaguar Health (JAGX) Other Non Operating Income (2015 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 12 years of Other Non Operating Income data on file, last reported at -$628000.0 in Q1 2026.
- Other Non Operating Income for Q1 2026 came in at -$628000.0, down 660.71% year-over-year; the trailing twelve-month figure through Mar 2026 was -$679000.0 (down 51.22% YoY), and the FY2025 annual result was $43000.0, down 96.55% from the prior year.
- Other Non Operating Income declined to -$628000.0 in Q1 2026 per JAGX's latest filing, from $1.9 million in the prior quarter.
- Over five years, Other Non Operating Income peaked at $3.8 million in Q4 2023 and troughed at -$1.8 million in Q2 2025.
- A 5-year average of $408812.5 and a median of $7000.0 in 2023 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2022 and 2024: Other Non Operating Income plunged 6276.47% in 2022, then jumped 10475.0% in 2024.
- A 5-year view of Other Non Operating Income shows it stood at $3.1 million in 2022, then increased by 19.64% to $3.8 million in 2023, then tumbled by 95.52% to $168000.0 in 2024, then surged by 1010.12% to $1.9 million in 2025, then tumbled by 133.67% to -$628000.0 in 2026.
- Business Quant data shows JAGX's Other Non Operating Income at -$628000.0 in Q1 2026, $1.9 million in Q4 2025, and -$94000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -628,000.00 |
| Dec 31, 2025 | 1.87 Mn |
| Sep 30, 2025 | -94,000.00 |
| Jun 30, 2025 | -1.82 Mn |
| Mar 31, 2025 | 112,000.00 |
| Sep 30, 2024 | 168,000.00 |
| Jun 30, 2024 | -729,000.00 |
| Mar 31, 2024 | 1.25 Mn |
| Dec 31, 2023 | 3.75 Mn |
| Sep 30, 2023 | -70,000.00 |
| Jun 30, 2023 | 26,000.00 |
| Mar 31, 2023 | -12,000.00 |
| Dec 31, 2022 | 3.14 Mn |
| Sep 30, 2022 | -158,000.00 |
| Jun 30, 2022 | -1.08 Mn |
| Mar 31, 2022 | 832,000.00 |
| Sep 30, 2021 | -20,000.00 |
| Jun 30, 2021 | -17,000.00 |
| Mar 31, 2021 | 10,000.00 |
| Dec 31, 2020 | -1.30 Mn |